Selective screening for neonatal galactosemia: an alternative approach.
No universal consensus exists for population-based neonatal screening for galactosemia. In our institution, selective screening for classical galactosemia is carried out on infants under 2 wk of age and those with symptoms suggestive of this disorder. Eighteen cases were diagnosed from 25,099 tests done; 17 were symptomatic at the time of diagnosis. We suggest that improved clinical vigilance and selective screening would identify most infants with severe galactosemia as early as a population-based program.